MDS

>

CURE’s myelodysplastic syndrome (MDS) page is an extensive resource of cancer information featuring the latest myelodysplastic syndrome news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on MDS.

Latest News

Illustration of Jane.
Moving Slower and Slower After Myelodysplastic Syndrome

February 12th 2025

I have been frustrated lately by my increasing slowness following an blood cancer diagnosis, which has become noticeable to others.

FDA Approved Image.
Breaking Down Cancer Therapies Approved by the FDA in January 2025

February 3rd 2025

Illustration of blood cells.
A Phase 1 Trial of Iadademstat Plus Vidaza Has Dosed a Patient With MDS

January 29th 2025

Jane Biehl is a 12-year survivor of a very rare form of blood cancer, known as myelodysplastic syndrome (MDS). Catch up on all of Jane’s blogs here!
Life After MDS and Accomplishing Your Goals

January 28th 2025

"FDA" text.
FDA Approves GRAFAPEX/Fludarabine Before alloHSCT in AML and MDS

January 24th 2025

More News